The stock of Livent Corp (NYSE:LTHM) last traded at $18.11, up 5.97% from the previous session.
Data from the available sources indicates that Livent Corp (NYSE:LTHM) is covered by 19 analysts. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $45.00 and a low of $27.00, we find $31.00. Given the previous closing price of $17.09, this indicates a potential upside of 81.39 percent. LTHM stock price is now -17.37% away from the 50-day moving average and -22.09% away from the 200-day moving average. The market capitalization of the company currently stands at $3.25B.
In total, 4 analysts have assigned it a hold rating, and 13 have given it a buy rating. Brokers who have rated the stock have averaged $32.32 as their price target over the next twelve months.
With the price target maintained at $30, KeyBanc Capital Markets recently Upgraded its rating from Sector Weight to Overweight for Livent Corp (NYSE: LTHM).
Insiders disposed of 29,907 shares of company stock worth roughly $0.54 million over the past 1 year. A total of 0.78% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in LTHM stock. A new stake in Livent Corp shares was purchased by SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC during the first quarter worth $17,043,000. JOHO CAPITAL LLC invested $12,858,000 in shares of LTHM during the first quarter. In the first quarter, PEREGRINE CAPITAL MANAGEMENT LLC acquired a new stake in Livent Corp valued at approximately $6,758,000. LISANTI CAPITAL GROWTH, LLC acquired a new stake in LTHM for approximately $5,011,000. YAUPON CAPITAL MANAGEMENT LP purchased a new stake in LTHM valued at around $3,951,000 in the second quarter. In total, there are 629 active investors with 99.56% ownership of the company’s stock.
With an opening price of $17.20 on Thursday morning, Livent Corp (NYSE: LTHM) set off the trading day. During the past 12 months, Livent Corp has had a low of $16.93 and a high of $35.81. As of last week, the company has a debt-to-equity ratio of 0.15, a current ratio of 3.76, and a quick ratio of 2.37. According to the stock market information, the enterprise value for the company is $3.34B, which is based on a 10.38 price-to-earnings ratio, a 0.34 price-to-earnings-growth ratio, and a beta of 1.87. The fifty day moving average price for LTHM is $21.92 and a two-hundred day moving average price translates $23.25 for the stock.
The latest earnings results from Livent Corp (NYSE: LTHM) was released for Jun, 2023. According to the Specialty Chemicals Company, earnings per share came in at $0.51, beating analysts’ expectations of $0.47 by 0.04. This compares to $0.31 EPS in the same period last year. The net profit margin was 38.85% and return on equity was 24.91% for LTHM. The company reported revenue of $235.8 million for the quarter, compared to $218.7 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 7.82 percent. For the current quarter, analysts expect LTHM to generate $273.96M in revenue.
Livent Corp(LTHM) Company Profile
Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in non-rechargeable batteries and the production of lightweight materials for aerospace applications. It also provides lithium phosphate, pharmaceutical-grade lithium carbonate, high purity lithium chloride, and specialty organics; and lithium carbonate and lithium chloride for use as feedstock in the process of producing performance lithium compounds. The company was founded in 1940 and is headquartered in Philadelphia, Pennsylvania.
